Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

myeloproliferative neoplasm, unclassifiable - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

myeloproliferative neoplasm, unclassifiable

MONDO:0019452

Also known as:CMPD, UCMPD-UMPN, U

Find Clinical TrialsTrials

Overview

This subgroup of myeloproliferative neoplasms includes cases which do not meet the morphologic criteria of any of the defined myeloproliferative neoplasms, or which have characteristics that overlap at least two of the myeloproliferative neoplasms.

Clinical Trials6 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for myeloproliferative neoplasm, unclassifiable has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

6 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, gene therapy, and procedural interventions. Pipeline includes 1 PHASE2, 2 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05326919](https://clinicaltrials.gov/study/NCT05326919)

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:22 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:86830

GARD

Genetic and Rare Diseases Info Center

GARD:16764

Questions for Your Care Team

→Are any of the 6 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Other research	7	23%
Patient case studies	7	23%
Research summaries	6	20%
Disease patterns and progression	5	17%
Laboratory research	4	13%
Testing and diagnosis research	1	3%

myeloproliferative neoplasm, unclassifiable

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications